121
Views
0
CrossRef citations to date
0
Altmetric
Original Research

A Novel Prognostic Score Based on ZG16 for Predicting CRC Survival

, , , , & ORCID Icon
Pages 735-747 | Published online: 16 Dec 2020

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2018.
  • Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691. doi:10.1136/gutjnl-2015-31091226818619
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.2155130620402
  • Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good or bad news from the 2018 global cancer statistics? Cancer Commun. 2019;39(1):22. doi:10.1186/s40880-019-0368-6
  • Simon K. Colorectal cancer development and advances in screening. Clin Interv Aging. 2016;11:967–976. doi:10.2147/CIA.S10928527486317
  • Nitsche U, Maak M, Schuster T, et al. Prediction of prognosis is not improved by the seventh and latest edition of the TNM classification for colorectal cancer in a single-center collective. Ann Surg. 2011;254(5):793–800; discussion 800–791. doi:10.1097/SLA.0b013e3182369101
  • Bindea G, Mlecnik B, Hackl H, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091–1093. doi:10.1093/bioinformatics/btp10119237447
  • Markovic S, Dimitrijevic I, Zogovic B, Markovic V, Barisic G, Krivokapic Z. Current trends in clinical genetics of colorectal cancer. J buon. 2016;21(5):1042–1049.27837603
  • Kolenčík D, Shishido SN, Pitule P, Mason J, Hicks J, Kuhn P. Liquid biopsy in colorectal carcinoma: clinical applications and challenges. Cancers. 2020;12:6.
  • Mito A, Nakano Y, Saitoh T, et al. Lectin ZG16p inhibits proliferation of human colorectal cancer cells via its carbohydrate-binding sites. Glycobiology. 2018;28(1):21–31. doi:10.1093/glycob/cwx08829069492
  • Tateno H, Yabe R, Sato T, et al. Human ZG16p recognizes pathogenic fungi through non-self polyvalent mannose in the digestive system. Glycobiology. 2012;22(2):210–220. doi:10.1093/glycob/cwr13021893569
  • Rodríguez-Piñeiro AM, Bergström JH, Ermund A, et al. Studies of mucus in mouse stomach, small intestine, and colon. II. Gastrointestinal mucus proteome reveals Muc2 and Muc5ac accompanied by a set of core proteins. Am J Physiol Gastrointest Liver Physiol. 2013;305(5):G348–356. doi:10.1152/ajpgi.00047.201323832517
  • Johansson ME, Gustafsson JK, Holmén-Larsson J, et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut. 2014;63(2):281–291. doi:10.1136/gutjnl-2012-30320723426893
  • Kanagawa M, Satoh T, Ikeda A, et al. Crystal structures of human secretory proteins ZG16p and ZG16b reveal a Jacalin-related β-prism fold. Biochem Biophys Res Commun. 2011;404(1):201–205. doi:10.1016/j.bbrc.2010.11.09321110947
  • Meng H, Li W, Boardman LA, Wang L. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer. BMC Cancer. 2018;18(1):433. doi:10.1186/s12885-018-4337-229661177
  • Pelaseyed T, Bergström JH, Gustafsson JK, et al. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system. Immunol Rev. 2014;260(1):8–20. doi:10.1111/imr.1218224942678
  • Chen X, Du P, She J, Cao L, Li Y, Xia H. Loss of ZG16 is regulated by miR-196a and contributes to stemness and progression of colorectal cancer. Oncotarget. 2016;7(52):86695–86703. doi:10.18632/oncotarget.1343527880730
  • Escudero-Paniagua B, Bartolomé RA, Rodríguez S, et al. PAUF/ZG16B promotes colorectal cancer progression through alterations of the mitotic functions and the Wnt/β-catenin pathway. Carcinogenesis. 2020;41(2):203–213.31095674
  • Gao X, Yang J. Identification of genes related to clinicopathological characteristics and prognosis of patients with colorectal cancer. DNA Cell Biol. 2020;39(4):690–699. doi:10.1089/dna.2019.508832027181
  • Xu H, Ma Y, Zhang J, et al. Identification and verification of core genes in colorectal cancer. Biomed Res Int. 2020;2020:8082697.32462020
  • Zhao ZW, Fan XX, Yang LL, et al. The identification of a common different gene expression signature in patients with colorectal cancer. Math Biosci Eng. 2019;16(4):2942–2958. doi:10.3934/mbe.201914531137244
  • Sagaert X, Vanstapel A, Verbeek S. Tumor heterogeneity in colorectal cancer: what do we know so Far? Pathobiology. 2018;85(1–2):72–84. doi:10.1159/00048672129414818
  • Li W, Qiu T, Zhi W, et al. Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages. BMC Cancer. 2015;15:340.25929517
  • Mármol I, Sánchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ. Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci. 2017;18:1. doi:10.3390/ijms18010197